FDA Adverse Event Other Summary report: N

ULTRAPULSE XL 3000/5000

MDR report key: 834634 · Received March 30, 2007

Report

Report Number
2914019-2007-00008
Event Type
Other
Date Received
March 30, 2007
Date of Event
February 15, 2007
Report Date
March 30, 2007
Manufacturer
LUMENIS, INC.
Product Code
GEX
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

PER THE PHYSICIAN, THE ROOT CAUSE OF THE INCIDENT IS PATIENT PREDISPOSITION TO KELOID SCARRING (ROOT CAUSE NOT RELATED TO THE LUMENIA DEVICE). LUMENIS REGULATORY DID NOT RECOMMEND DEVICE EVALUATION.

Description of Event or Problem · 1

PER THE PHYSICIAN, AT 3 DAYS POST-CO2 RESURFACING TO THE FACE THE PHYSICIAN REMOVED THE SALINE DRESSING. NO PROBLEMS NOTED. AT 4 DAYS POST-CO2 RESURFACING, THE SKIN ON THE CHEEKS BEGAN TO BREAK DOWN PER THE PHYSICIAN, THE PATIENT WAS BEGINNING TO DEVELOP KELOID SCARRING. PER THE PHYSICIAN, THE ROOT CAUSE WAS PATIENT PREDISPOSITION; PATIENT HAD A REMOTE HISTORY OF A KELOID SCAR FROM A HYSTERECTOMY APPROXIMATELY 23 YEARS AGO. THE PATIENT MAY ALSO HAVE APPLIED EXCESSIVE AQUAPHOR AFTER THE RESURFACING TREATMENT, PER THE PHYSICIAN. MEDICAL INTERVENTION CONSISTED OF SEVERAL INJECTIONS OF LOW-DOSE TRIAMELNOLONE (3MG/CC) TO THE AFFECTED AREA IN 2007. LATER PATIENT WAS GIVEN DICLOXACILLIN ANTIBIOTIC ALTHOUGH A CULTURE RESULTED NORMAL (NO INFECTION). PER REPORT FROM THE PHYSICIAN, LATER THE PATIENT WAS TREATED WITH 5-FLUOROURACIL, V-BEAM, AND STILL LAER WITH A LITTLE MORE5-FLUOROURACIL. TREATMENT. PER THE PHYSICIAN, THE CONDITION WAS COMPLETELY RESOLVED WITHOUT ANY SCARRING AS OF 2007.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ULTRAPULSE XL 3000/5000 CARBON DIOXIDE SURGICAL LASER GEX LUMENIS, INC. * *

Patients

Seq Age Sex Outcome Treatment
1 * Required Intervention NONE REPORTED